Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY 4.0Biomolecules

Myocardial Ischemia–Reperfusion Injury: Targeted Mechanism Network and Emerging Therapeutic Strategies

  1. 1Department of Cardiology, Cardiovascular Disease Center, Jiangsu Key Laboratory for Cardiovascular Information and Health Engineering Medicine, Nanjing Drum Tower Hospital, Medical School, Nanjing University, No. 321 Zhongshan Road, Nanjing 210093, China

Abstract

Myocardial ischemia–reperfusion injury (MI/RI) is a common complication of cardiovascular disease management. Although revascularization strategies, including percutaneous coronary intervention and coronary artery bypass grafting, can restore blood flow, myocardial structure and function often remain incompletely recovered. Reperfusion can also cause additional tissue damage. This paradoxical exacerbation is largely attributable to oxidative stress and inflammatory responses. In this narrative review, we summarize recent advances in the mechanistic understanding of myocardial ischemia–reperfusion injury and evaluate emerging therapeutic strategies. These approaches hold considerable promise and may provide novel preclinical evidence and clinical translation insights for improving prevention and management of reperfusion injury.

Related

  1. Pyroptosis in myocardial ischemia-reperfusion injury: mechanistic pathways and therapeutic prospects.
    Shenshen Ding, Xiaoding Zhang, Zuxian Sheng +2
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
  2. TRPV4-linked oxidative–lysosomal stress in myocardial ischemia/reperfusion: disease-matched transcriptomics and functional analysis in OGD/R cardiomyoblasts
    Jie Yang, Jincheng Li, Guanyao Li +12
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  3. Discovery of metabolite biomarkers for cerebral ischemia-reperfusion injury based on metabolomics: neurotoxic mechanism and functional validation of a flavopiridol -related metabolite
    Zhi-guang Song, Yu-chen Liu, Zhen-lin Zhong +12
    Frontiers in molecular biosciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  4. Carnosic Acid Attenuates Lipotoxicity-Mediated Myocardial Ischemia–Reperfusion Injury by Suppressing Complex I ROS and Modulating the SIRT1–UPRmt Axis
    Xiaobing Shi, Man Wang, Xiaowei Zhou +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  5. Pectolinarigenin and Diosmetin Ameliorate Myocardial Ischemia–Reperfusion Injury by Activating PPARγ/GLUT4 Pathway
    Yunfei Wang, Jing Zhou, Changhan Ma +8
    MetabolitesPeer-reviewedCC BY 4.0Proteomics & metabolomicsCrossref
BibTeX
@article{cai2026myocardial,
  title = {{Myocardial Ischemia–Reperfusion Injury: Targeted Mechanism Network and Emerging Therapeutic Strategies}},
  author = {Yue Cai and Huiqing Ding and Sen Yan and Yuchen Wen and Biao Xu and Xuan Sun},
  journal = {Biomolecules},
  year = {2026},
  month = nov,
  doi = {10.3390/biom16111655},
  url = {https://www.mdpi.com/2218-273X/16/11/1655},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Myocardial Ischemia–Reperfusion Injury: Targeted Mechanism Network and Emerging Therapeutic Strategies
AU  - Yue Cai
AU  - Huiqing Ding
AU  - Sen Yan
AU  - Yuchen Wen
AU  - Biao Xu
AU  - Xuan Sun
PY  - 2026
DA  - 2026/11/12
JO  - Biomolecules
DO  - 10.3390/biom16111655
UR  - https://www.mdpi.com/2218-273X/16/11/1655
AB  - Myocardial ischemia–reperfusion injury (MI/RI) is a common complication of cardiovascular disease management. Although revascularization strategies, including percutaneous coronary intervention and coronary artery bypass grafting, can restore blood flow, myocardial structure and function often remain incompletely recovered. Reperfusion can also cause additional tissue damage. This paradoxical exacerbation is largely attributable to oxidative stress and inflammatory responses. In this narrative review, we summarize recent advances in the mechanistic understanding of myocardial ischemia–reperfusion injury and evaluate emerging therapeutic strategies. These approaches hold considerable promise and may provide novel preclinical evidence and clinical translation insights for improving prevention and management of reperfusion injury.
SN  - 2218-273X
ER  -